Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study.
Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice.
Considering the influence of stimulation parameters on the effect of conventional and high-definition transcranial direct current stimulation.
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases.
Drak2 Does Not Regulate TGF-β Signaling in T Cells.
Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis.
A high-density screen for linkage in multiple sclerosis.
Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis.
Circulating monocytes are reduced by sphingosine-1-phosphate receptor modulators independently of S1P3.
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response.
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Rescue Therapy Using Rituximab for Multiple Sclerosis.
Does interferon Beta-1a impact pure-tone hearing sensitivity among individuals with multiple sclerosis?
Predictive value of early brain atrophy on response in patients treated with interferon β.
Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.
The history of the oxazaphosphorine cytostatics.
Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer.
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α
Phase II Cladribine Add-on to Interferon-beta (IFN-b) Therapy in MS Subjecs With Active Disease (ONWARD)
Safety issue puts daclizumab in doubt for MS
Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial.
Apitope Announces Positive Results from Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis.
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.

Pages